No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
MRK250117P175000
- 0.00
- 0.000.00%
15min DelayClose Jan 14 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest175.00Strike Price0.00Turnover341.44%IV-75.61%PremiumJan 17, 2025Expiry Date75.35Intrinsic Value100Multiplier3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9576Delta0.0031Gamma1.32Leverage Ratio-0.3425Theta-0.0099Rho-1.26Eff Leverage0.0079Vega
Intraday
- 5D
- Daily
No Data
News
Jim Cramer Says He Supports Healthcare Stocks for Their Long-term Value
Boeing, NVIDIA Corp. Share Losses Lead Dow's 113-Point Drop
BMO Capital Maintains Merck & Co(MRK.US) With Hold Rating, Maintains Target Price $105
Jefferies Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $150
Merck & Co.'s Accelerated Keytruda Launch and Strategic Updates Bolster Long-term Growth Prospects
Merck Eyeing 2025 Launch for Easier-to-use Keytruda